Business Wire

Octave Presents Clinical Validation Results of its Multivariate Blood-based Multiple Sclerosis Disease Activity Biomarker Test at ACTRIMS Forum 2022

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave, the developer of a fully-integrated Precision Care Solution built to deliver comprehensive insights that bring scientific clarity to multiple sclerosis (MS ...
Financial Times

Octave® Bioscience, Inc. Announces Publication of Clinical Validation Study Results of its Novel, Multivariate Multiple Sclerosis Disease Activity (MSDA) Blood Test

MENLO PARK, Calif.--(BUSINESS WIRE)--Aug. 30, 2023-- Octave ® Bioscience, Inc., a leading precision care company focused on delivering a new standard of care for multiple sclerosis (MS) and other ...